FDA carbendazim measures reassessment refusal meets industry backlash
The US Food and Drug Administration (FDA) has refused to move on allowable levels of carbendazim in orange juice product imports – meeting disapproval from the US industry.
Archives for February 20, 2012
Amcor profits rise on steady demand and cost cuts
Amcor said strong performance across the board in its flexible and rigid packaging divisions fuelled a 14% profit increase in the first half of the year as recent acquisitions of Ball and Alcan continued to reap rewards.
Thermo Fisher puts ‘global’ carbendazim orange juice issue to the test
Thermo Fisher Scientific says it has internally validated a faster and more accurate new method for detecting residue levels of carbendazim in oranges and orange juice than one technique now being used by the US FDA to test Brazilian imports.
POM under fire again in class action suit over deceptive claims
POM Wonderful has come under fire again for allegedly misleading and deceiving consumers about the health benefits of its antioxidant-packed wares in a new class action lawsuit.